← Back to Skills Marketplace
hanxueyuan

Astellas

by hanxueyuan · GitHub ↗ · v1.0.0 · MIT-0
cross-platform ✓ Security Clean
36
Downloads
0
Stars
0
Active Installs
1
Versions
Install in OpenClaw
/install astellas
Description
Japanese pharmaceutical company specializing in oncology, urology, and immunology with a global R&D network and advanced cell and gene therapy programs.
README (SKILL.md)

Astellas — Japanese Pharma Innovation

历史时间线

  • 2005: Formed by merger of Yamanouchi Pharmaceutical (founded 1877) and Fujisawa Pharmaceutical (founded 1902)
  • 2000s: Establishes global R&D centers in US, Europe, and Asia
  • 2010s: Focuses on oncology, urology, transplant, and infectious diseases
  • 2018: Launches Xtandi (prostate cancer) as blockbuster drug
  • 2020s: Invests heavily in cell therapy and gene therapy through Astellas Ventures
  • 2024: Expanding into antibody-drug conjugates (ADCs) and regenerative medicine

商业模式

  • Prescription drugs: Focus on specialty pharmaceuticals
  • Therapeutic areas: Oncology, urology, immunology, neuroscience
  • Cell/gene therapy: Through acquisitions (Audentes Biotherapeutics)
  • Global presence: Operations in 70+ countries

护城河分析

  • R&D pipeline: Strong oncology and urology franchises
  • Japanese heritage: 150+ years of pharmaceutical expertise
  • Global R&D network: Centers in Cambridge (MA), Basel, Tokyo
  • ADC platform: Growing capabilities in antibody-drug conjugate technology

关键数据

  • Revenue: ¥1.4+ trillion (~$9B) annually
  • R&D spend: ¥200B+ annually (14%+ of revenue)
  • Employees: 15,000+ globally
  • Markets: 70+ countries

有趣事实

  • The Yamanouchi side of the merger was originally a traditional Japanese medicine (Kampo) manufacturer — the company's pharmaceutical heritage dates back to the Meiji era
  • Astellas' Xtandi became one of the best-selling prostate cancer drugs globally, generating over $3B in annual sales
Usage Guidance
This appears to be a low-risk informational skill. Before relying on the company facts for business or medical decisions, verify them against current primary sources, but no security-sensitive permissions are evident from the artifacts.
Capability Analysis
Type: OpenClaw Skill Name: astellas Version: 1.0.0 The skill bundle contains purely informational content regarding Astellas, a Japanese pharmaceutical company. The SKILL.md file provides historical context, business analysis, and key financial data without any executable code, network requests, or malicious instructions.
Capability Assessment
Purpose & Capability
The content is coherent with the stated purpose: a short informational profile of Astellas for pharma-industry research.
Instruction Scope
The skill provides reference material and read_when contexts only; it does not instruct the agent to override user goals, use tools, or take actions.
Install Mechanism
There is no install specification, no code, no required binaries, and no package or script execution.
Credentials
The skill requests no environment access, files, network, credentials, or local system capabilities.
Persistence & Privilege
No persistence, background behavior, privilege escalation, account access, or credential handling is present in the provided artifacts.
How to Use
  1. Make sure OpenClaw is installed (local or Docker)
  2. Run the install command in chat: /install astellas
  3. After installation, invoke the skill by name or use /astellas
  4. Provide required inputs per the skill's parameter spec and get structured output
Version History
v1.0.0
Astellas skill version 1.0.0 — Initial Release - Provides an overview of Astellas, a leading Japanese pharmaceutical company specializing in oncology, urology, and immunology. - Includes a historical timeline, business model, and key data on revenue, R&D spend, and global presence. - Covers Astellas’ strengths in research, global operations, and innovation in cell/gene therapy and ADCs. - Highlights unique facts about the company’s origins and flagship products. - Designed for those researching the Japanese pharma industry, drug development, or comparing pharma company strategies.
Metadata
Slug astellas
Version 1.0.0
License MIT-0
All-time Installs 0
Active Installs 0
Total Versions 1
Frequently Asked Questions

What is Astellas?

Japanese pharmaceutical company specializing in oncology, urology, and immunology with a global R&D network and advanced cell and gene therapy programs. It is an AI Agent Skill for Claude Code / OpenClaw, with 36 downloads so far.

How do I install Astellas?

Run "/install astellas" in the OpenClaw or Claude Code chat to install it in one step — no extra setup required.

Is Astellas free?

Yes, Astellas is completely free, licensed under MIT-0. You can download, install and use it at no cost.

Which platforms does Astellas support?

Astellas is cross-platform and runs anywhere OpenClaw / Claude Code is available (cross-platform).

Who created Astellas?

It is built and maintained by hanxueyuan (@hanxueyuan); the current version is v1.0.0.

💬 Comments